Both anti-HK1 and anti-KLHL12 are present in ∼37.5 and 40% of PBC patients who are negative for AMA alone, or are combined AMA, gp210 and Sp100 negative, respectively (Reig et al., 2020). Here, SP100 is linked to primary biliary cholangitis.